End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.089 AUD | +9.88% | +23.61% | +50.85% |
01:44am | Percheron Therapeutics Names Chief Medical Advisor | MT |
May. 29 | Percheron Therapeutics Completes Enrollment for Phase Two Muscular Dystrophy Trial; Shares Rise 3% | MT |
Quotes 5-day view
End-of-day quote Australian S.E.2024-05-28 | 2024-05-29 | 2024-05-30 | 2024-05-31 | Today | 2024-06-02 | |
---|---|---|---|---|---|---|
Last | 0.072 $ | 0.075 $ | 0.074 $ | 0.081 $ | 0.089 $ | 0.089 $ |
Volume | 109 710 | 556 616 | 678 235 | 903 683 | 2 428 157 | 2 428 157 |
Change | 0.00% | +4.17% | -1.33% | +9.46% | +9.88% | +9.88% |
Opening | 0.07 | 0.08 | 0.08 | 0.07 | 0.08 | 0.081 |
High | 0.07 | 0.08 | 0.08 | 0.08 | 0.09 | 0.094 |
Low | 0.07 | 0.07 | 0.07 | 0.07 | 0.08 | 0.081 |
Performance
1 day | +9.88% | ||
1 week | +23.61% | ||
Current month | +9.88% | ||
1 month | +15.58% | ||
3 months | +1.14% | ||
6 months | +48.33% | ||
Current year | +50.85% | ||
1 year | +48.33% | ||
3 years | -51.89% | ||
5 years | +71.15% | ||
10 years | -42.58% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Bio Therapeutic Drugs
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
+9.88% | +23.61% | +50.85% | +48.33% | 48.49M | ||
+2.52% | +4.62% | +14.90% | +39.80% | 118B | ||
+1.25% | +2.12% | +13.15% | +32.46% | 106B | ||
+1.30% | +9.02% | -2.80% | -5.65% | 24.28B | ||
+1.97% | +1.43% | +1.14% | -7.19% | 21.96B | ||
+0.85% | -0.08% | -9.35% | -28.78% | 18.16B | ||
-0.26% | -1.75% | -42.28% | -38.09% | 16.37B | ||
+0.02% | -2.00% | -16.81% | -32.36% | 15.56B | ||
+1.63% | -1.83% | +4.67% | +46.94% | 13.63B | ||
-4.65% | +9.20% | +28.34% | -1.91% | 12.27B | ||
+3.76% | +20.14% | +86.32% | +196.56% | 8.87B | ||
+0.94% | +7.87% | +9.05% | +49.49% | 7.75B | ||
+1.65% | +4.59% | +14.42% | +41.11% | 7.65B | ||
-0.87% | -1.28% | -4.54% | +23.40% | 7.42B | ||
-0.39% | -4.43% | -33.80% | -39.02% | 7.29B | ||
-1.76% | -5.92% | +230.41% | +166.53% | 6.87B | ||
Average | +1.13% | +11.10% | +21.48% | +30.73% | ||
Weighted average by Cap. | +1.33% | +3.43% | +11.85% | +26.21% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | +50.85% | ||
2023 | -39.18% | ||
2022 | -50.26% | ||
2021 | +50.00% | ||
2020 | +44.44% | ||
2019 | +246.15% | ||
2018 | +8.33% | ||
2017 | -33.33% | ||
2016 | -49.30% | ||
2015 | -21.11% | ||
2014 | -40.00% | ||
2013 | +36.36% | ||
2012 | -52.17% | ||
2011 | +228.57% | ||
2010 | -87.27% | ||
2009 | +57.14% | ||
2008 | -16.67% | ||
2007 | +5.01% | ||
2006 | +11.10% | ||
2005 | -71.20% | ||
2004 | 0.00% | ||
2003 | +76.05% | ||
2002 | -74.18% | ||
2001 | +14.58% |
- Stock Market
- Equities
- PER Stock
- Quotes Percheron Therapeutics Limited